Dr. Nezam Altorok
Claim this profileUniversity of Toledo
Studies Systemic Lupus Erythematosus
Studies Lupus
1 reported clinical trial
4 drugs studied
Clinical Trials Nezam Altorok is currently running
More about Nezam Altorok
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Nezam Altorok has experience with
- M5049 High Dose
- M5049 Low Dose
- M5049 Medium Dose
- Placebo
Breakdown of trials Nezam Altorok has run
Systemic Lupus Erythematosus
Lupus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nezam Altorok specialize in?
Nezam Altorok focuses on Systemic Lupus Erythematosus and Lupus. In particular, much of their work with Systemic Lupus Erythematosus has involved treating patients, or patients who are undergoing treatment.
Is Nezam Altorok currently recruiting for clinical trials?
Yes, Nezam Altorok is currently recruiting for 1 clinical trial in Toledo Ohio. If you're interested in participating, you should apply.
Are there any treatments that Nezam Altorok has studied deeply?
Yes, Nezam Altorok has studied treatments such as M5049 high dose, M5049 low dose, M5049 medium dose.
What is the best way to schedule an appointment with Nezam Altorok?
Apply for one of the trials that Nezam Altorok is conducting.
What is the office address of Nezam Altorok?
The office of Nezam Altorok is located at: University of Toledo, Toledo, Ohio 43614-2598 United States. This is the address for their practice at the University of Toledo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.